Emily Johnson

Emily Johnson

Auto-generated profile, based on publicly available information

Emily Johnson

Department of Biochemistry, Cell and Systems Biology; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Crown Street, Liverpool L69 7ZB, United Kingdom

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2017 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
RTRobi Tacutu
Robi Tacutu
DTDaniel Thornton
Daniel Thornton
EJEmily Johnson
Emily Johnson
ABArie Budovsky
Arie Budovsky
DBDiogo Barardo
Diogo Barardo
JMJoao Pedro Magalhaes
Joao Pedro Magalhaes
In spite of a growing body of research and data, human ageing remains a poorly understood process. Over 10 years ago we developed the Human Ageing Genomic Resources (HAGR), a collection of databases and tools for studying the biology and genetics of ageing. Here, we present HAGR’s main functionalities, highlighting new additions and improvements. HAGR consists of six core databases: (i) the GenAge database of ageing-related genes, in turn composed of a dataset of >300 human ageing-related genes and a dataset with >2000 genes associated with ageing or longevity in model organisms; (ii) the AnAge database of animal ageing and longevity, featuring >4000 species; (iii) the GenDR database with >200 genes associated with the life-extending effects of dietary restriction; (iv) the LongevityMap database of human genetic association studies of longevity with >500 entries; (v) the DrugAge database with >400 ageing or longevity-associated drugs or compounds; (vi) the CellAge database with >200 genes associated with cell senescence. All our databases are manually curated by experts and regularly updated to ensure a high quality data. Cross-links across our databases and to external resources help researchers locate and integrate relevant information. HAGR is freely available online (http://genomics.senescence.info/).

26 June 2026 in Science Advances
Verified
Journal Article
Open access
AMAlison Maclean
Alison Maclean
EJEmily Johnson
Emily Johnson
CRCorie Rushworth
Corie Rushworth
CHChristopher J. Hill
Christopher J. Hill
EGEva Caamaño Gutiérrez
Eva Caamaño Gutiérrez
DHDharani K. Hapangama
Dharani K. Hapangama
Adenomyosis is a common gynecological condition characterized by ectopic endometrial-like tissue deep within the myometrium, causing debilitating symptoms. Treatment options are limited to hormones that primarily focus on symptom management only or invasive hysterectomy. Despite its prevalence, the pathogenesis of adenomyosis remains poorly understood, considerably impeding the development of targeted, true disease modifying treatments. Here, through spatial transcriptomics analysis of full-thickness human uterine wall biopsies ( n = 10), we demonstrate that adenomyosis lesions exhibit a distinct transcriptomic profile, intermediate between matched endometrium and myometrium, characterized by enhanced epithelial ciliation and altered biological pathways. We reveal that adenomyosis lesion transcriptome more closely resembles the endometrial basalis than the functionalis, marked by enriched olfactory signaling, dysregulated oxidative phosphorylation and adenosine triphosphate synthesis, and an altered immune microenvironment indicative of chronic inflammation. In silico drug screening identified candidate compounds capable of reversing the adenomyosis lesion transcriptomic signature. These findings offer previously unknown insights into the molecular landscape of adenomyosis lesions and lay the groundwork for development of targeted, lesion-specific therapies that may preserve the eutopic endometrium and offer alternatives to hysterectomy.

27 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAdam J. Simpkin
Adam J. Simpkin
EJEmily J. Johnson
Emily J. Johnson
DRDaniel J. Rigden
Daniel J. Rigden
Motivation: The actual interface pTM score (actifpTM) is a modified version of the ipTM score that limits the calculation to only those residues at the interface. Whilst actifpTM provides an effective interface quality score, a limiting factor is that it makes use of the predicted aligned error (PAE) with probabilities, information that is generated during a ColabFold run, but not output by the package or other model prediction software. The consequent inability to generate actifpTM scores for the results of software such as AlphaFold 2 or AlphaFold 3 has limited its adoption. With reactifpTM we address this problem by providing a standalone tool that can be run on the standard outputs of most model prediction packages. Results: Using the same underlying principles as actifpTM, reactifpTM has been developed to use standard output files from model prediction software (a model and corresponding PAE) to perform an actifpTM-like calculation. ColabFold models were generated for a dataset of 1079 known interfaces in the PDB. A strong correlation was shown between actifpTM and reactifpTM for this dataset. Availability and implementation: reactifpTM is coded in Python. All scripts and associated documentation are available from https://github.com/hlasimpk/reactifptm or https://pypi.org/project/reactifptm . Contact: drigden@liverpool.ac.uk